UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 388

Sortiert nach

New β-Lactam-β-Lactamase Inhibitor Combinations

Clinical microbiology reviews, 2020-12, Vol.34 (1)

2020

Link zum Volltext

Verfügbarkeit prüfen

Detection and treatment options for Klebsiella pneumoniae carbapenemases (KPCs): an emerging cause of multidrug-resistant infection

Journal of antimicrobial chemotherapy, 2010-06, Vol.65 (6), p.1119-1125

2010

Link zum Volltext

Verfügbarkeit prüfen

Framework for optimisation of the clinical use of colistin and polymyxin B: the Prato polymyxin consensus

The Lancet infectious diseases, 2015-02, Vol.15 (2), p.225-234

2015

Link zum Volltext

Verfügbarkeit prüfen

Rapid In Vitro Assessment of Antimicrobial Drug Effect Bridging Clinically Relevant Pharmacokinetics: A Comprehensive Methodology

Pharmaceutics, 2023-06, Vol.15 (6), p.1671

2023

Link zum Volltext

Verfügbarkeit prüfen

Characterization of Polymyxin B-Induced Nephrotoxicity: Implications for Dosing Regimen Design

Antimicrobial Agents and Chemotherapy, 2012-09, Vol.56 (9), p.4625-4629

2012

Link zum Volltext

Verfügbarkeit prüfen

In Vitro Activity of MK-7655, a Novel β-Lactamase Inhibitor, in Combination with Imipenem against Carbapenem-Resistant Gram-Negative Bacteria

Antimicrobial Agents and Chemotherapy, 2012-07, Vol.56 (7), p.3753-3757

2012

Link zum Volltext

Verfügbarkeit prüfen

Pharmacokinetics and Renal Disposition of Polymyxin B in an Animal Model

Antimicrobial Agents and Chemotherapy, 2012-11, Vol.56 (11), p.5724-5727

2012

Link zum Volltext

Verfügbarkeit prüfen

Impact of Multidrug-Resistant Pseudomonas aeruginosa Bacteremia on Patient Outcomes

Antimicrobial Agents and Chemotherapy, 2010-09, Vol.54 (9), p.3717-3722

2010

Link zum Volltext

Verfügbarkeit prüfen

A novel approach to pharmacodynamic assessment of antimicrobial agents: new insights to dosing regimen design

PLoS computational biology, 2011-01, Vol.7 (1), p.e1001043

2011

Link zum Volltext

Verfügbarkeit prüfen

Clinical and genomic analysis of virulence-related genes in bloodstream infections caused by Acinetobacter baumannii

Virulence, 2022-12, Vol.13 (1), p.1920-1927

2022

Link zum Volltext

Verfügbarkeit prüfen

Surveillance and Correlation of Antibiotic Prescription and Resistance of Gram-Negative Bacteria in Singaporean Hospitals

Antimicrobial Agents and Chemotherapy, 2010-03, Vol.54 (3), p.1173-1178

2010

Link zum Volltext

Verfügbarkeit prüfen

Temporal Interplay between Efflux Pumps and Target Mutations in Development of Antibiotic Resistance in Escherichia coli

Antimicrobial Agents and Chemotherapy, 2012-04, Vol.56 (4), p.1680-1685

2012

Link zum Volltext

Verfügbarkeit prüfen

Prevalence, Resistance Mechanisms, and Susceptibility of Multidrug-Resistant Bloodstream Isolates of Pseudomonas aeruginosa

Antimicrobial Agents and Chemotherapy, 2010-03, Vol.54 (3), p.1160-1164

2010

Link zum Volltext

Verfügbarkeit prüfen

Nebulized Colistin in the Treatment of Pneumonia Due to Multidrug-Resistant Acinetobacter baumannii and Pseudomonas aeruginosa

Clinical infectious diseases, 2005-09, Vol.41 (5), p.754-757

2005

Link zum Volltext

Verfügbarkeit prüfen

Outcomes of Appropriate Empiric Combination versus Monotherapy for Pseudomonas aeruginosa Bacteremia

Antimicrobial Agents and Chemotherapy, 2013-03, Vol.57 (3), p.1270-1274

2013

Link zum Volltext

Verfügbarkeit prüfen

A Common Polymorphism in the Interleukin-8 Gene Promoter Is Associated with an Increased Risk for Recurrent Clostridium difficile Infection

Clinical infectious diseases, 2010-12, Vol.51 (12), p.1406-1410

2010

Link zum Volltext

Verfügbarkeit prüfen

Transcriptional profiles of pulmonary innate immune responses to isogenic antibiotic‐susceptible and multidrug‐resistant Pseudomonas aeruginosa

Microbiology and immunology, 2018-04, Vol.62 (4), p.291-294

2018

Link zum Volltext

Verfügbarkeit prüfen

Novel Modeling Framework To Guide Design of Optimal Dosing Strategies for β-Lactamase Inhibitors

Antimicrobial Agents and Chemotherapy, 2012-05, Vol.56 (5), p.2237-2240

2012

Link zum Volltext

Verfügbarkeit prüfen

Optimization of Meropenem Minimum Concentration/MIC Ratio To Suppress In Vitro Resistance of Pseudomonas aeruginosa

Antimicrobial Agents and Chemotherapy, 2005-12, Vol.49 (12), p.4920-4927

2005

Link zum Volltext

Verfügbarkeit prüfen

The Relationship between Quinolone Exposures and Resistance Amplification Is Characterized by an Inverted U: a New Paradigm for Optimizing Pharmacodynamics To Counterselect Resistance

Antimicrobial Agents and Chemotherapy, 2007-02, Vol.51 (2), p.744-747

2007

Link zum Volltext

Verfügbarkeit prüfen

Comparison of cefiderocol in-vitro susceptibility testing modalities

Journal of global antimicrobial resistance., 2024-06, Vol.37, p.100-101

2024

Link zum Volltext

Verfügbarkeit prüfen

In vitro activity of tigecycline and proteomic analysis of tigecycline adaptation strategies in clinical Enterococcus faecalis isolates from China

Journal of global antimicrobial resistance., 2022-09, Vol.30, p.66-74

2022

Link zum Volltext

Verfügbarkeit prüfen

Clinical outcomes of cystic fibrosis patients with Pseudomonas aeruginosa bloodstream infection

Journal of global antimicrobial resistance., 2022-06, Vol.29, p.551-552

2022

Link zum Volltext

Verfügbarkeit prüfen

Pharmacodynamics of Polymyxin B against Pseudomonas aeruginosa

Antimicrobial Agents and Chemotherapy, 2005-09, Vol.49 (9), p.3624-3630

2005

Link zum Volltext

Verfügbarkeit prüfen

Development and validation of a highly sensitive LC–MS/MS assay for the quantification of arginine vasopressin in human plasma and urine: Application in preterm neonates and child

Journal of pharmaceutical and biomedical analysis, 2014-10, Vol.99, p.67-73

2014

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 388

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(366)
Mit Volltextzugriff
(366)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(325)
Life Sciences & Biomedicine
(289)
Humans
(198)
Pharmacology & Pharmacy
(124)
Microbiology
(123)
Biological And Medical Sciences
(112)
Female
(109)
Medical Sciences
(109)
Male
(102)
Infectious Diseases
(91)
Animals
(69)
Microbial Sensitivity Tests
(56)
Pharmacology. Drug Treatments
(56)
Middle Aged
(55)
Adult
(52)
Aged
(50)
Anti-Bacterial Agents - Pharmacology
(50)
Antibiotics. Antiinfectious Agents. Antiparasitic Agents
(47)
Mice
(40)
Pseudomonas Aeruginosa
(37)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

New β-Lactam-β-Lactamase Inhibitor Combinations

Detection and treatment options for Klebsiella pneumoniae carbapenemases (KPCs): an emerging cause of multidrug-resistant infection

Framework for optimisation of the clinical use of colistin and polymyxin B: the Prato polymyxin consensus

Rapid In Vitro Assessment of Antimicrobial Drug Effect Bridging Clinically Relevant Pharmacokinetics: A Comprehensive Methodology

Characterization of Polymyxin B-Induced Nephrotoxicity: Implications for Dosing Regimen Design

In Vitro Activity of MK-7655, a Novel β-Lactamase Inhibitor, in Combination with Imipenem against Carbapenem-Resistant Gram-Negative Bacteria

Pharmacokinetics and Renal Disposition of Polymyxin B in an Animal Model

Impact of Multidrug-Resistant Pseudomonas aeruginosa Bacteremia on Patient Outcomes

A novel approach to pharmacodynamic assessment of antimicrobial agents: new insights to dosing regimen design

Clinical and genomic analysis of virulence-related genes in bloodstream infections caused by Acinetobacter baumannii

Surveillance and Correlation of Antibiotic Prescription and Resistance of Gram-Negative Bacteria in Singaporean Hospitals

Temporal Interplay between Efflux Pumps and Target Mutations in Development of Antibiotic Resistance in Escherichia coli

Prevalence, Resistance Mechanisms, and Susceptibility of Multidrug-Resistant Bloodstream Isolates of Pseudomonas aeruginosa

Nebulized Colistin in the Treatment of Pneumonia Due to Multidrug-Resistant Acinetobacter baumannii and Pseudomonas aeruginosa

Outcomes of Appropriate Empiric Combination versus Monotherapy for Pseudomonas aeruginosa Bacteremia

A Common Polymorphism in the Interleukin-8 Gene Promoter Is Associated with an Increased Risk for Recurrent Clostridium difficile Infection

Transcriptional profiles of pulmonary innate immune responses to isogenic antibiotic‐susceptible and multidrug‐resistant Pseudomonas aeruginosa

Novel Modeling Framework To Guide Design of Optimal Dosing Strategies for β-Lactamase Inhibitors

Optimization of Meropenem Minimum Concentration/MIC Ratio To Suppress In Vitro Resistance of Pseudomonas aeruginosa

The Relationship between Quinolone Exposures and Resistance Amplification Is Characterized by an Inverted U: a New Paradigm for Optimizing Pharmacodynamics To Counterselect Resistance

Comparison of cefiderocol in-vitro susceptibility testing modalities

In vitro activity of tigecycline and proteomic analysis of tigecycline adaptation strategies in clinical Enterococcus faecalis isolates from China

Clinical outcomes of cystic fibrosis patients with Pseudomonas aeruginosa bloodstream infection

Pharmacodynamics of Polymyxin B against Pseudomonas aeruginosa

Development and validation of a highly sensitive LC–MS/MS assay for the quantification of arginine vasopressin in human plasma and urine: Application in preterm neonates and child

Suchergebnisse filtern